Stem Cell Company Stocks 9/20/09

For the most part, the stem cell stocks are still individually driven by news. However, many of the larger cap names seem to be moving higher along with the overall market. We'll see if that continues to hold true as the market inches closer to DOW 10000.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Stem Cell Therapy Intl (SCII.OB) = Up 614%; This stock spiked when the company agreed to be a party to a settlement where Histostem and Stem Cell Therapy Intl merge. This was a monstrous gain for such a small and obscure stock. It's already pulled back a lot from a high of $0.50/share, but I would still be hesitant to chase.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Osiris Therapeutics (OSIR) = Down -35%; This stock's stem cell drug failed two late stage studies and the CFO quit. Talk about a stock killer. I'd wait for this one to cool off some before I'd even consider buying.

Stem Cell Stocks Current Price and % Up or Down 9/07/09 - 9/18/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.51; Up 7%
Aastrom Biosciences (ASTM) = Cur Price: $0.424; Down -1%
BioTime, Inc. (BTIM) = Cur Price: $4.50; Up 29%

Celgene Corp (CELG) = Cur Price: $52.54; Up 2%

Cytori Therapeutics (CYTX) = Cur Price: $3.55; Up 14%
Geron Corp (GERN) = Cur Price: $7.41; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.644; Up 4%
Osiris Therapeutics (OSIR) = Cur Price: $7.97; Down -35%
StemCell Inc. (STEM) = Cur Price: $1.74; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.129; Down -17%
Athersys Inc. (ATHX) = Cur Price: $1.05; Up 7%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.275; Up 15%
Bioheart Inc. (BHRT) = Cur Price: $2.10; Up 173%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0031; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.10; Down -7%
Neuralstem (CUR) = Cur Price: $1.87; Up 64%
International Stem Cell (ISCO.OB) = Cur Price: $0.86; Up 5%
MultiCell Technologies (MCET.OB) = Cur Price: $0.022; Down -6%
Pluristem Therapeutics (PSTI) = Cur Price: $1.30; Down -1%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.25; Up 614%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0028; Down -7%


Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

1 comment:

  1. There are several techniques to apply this things.on the other hand everyone is taking their advices and are using this in many ways so that they can gain success quickly.